Buhr; Chris A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Buhr; Chris A..The latest application filed is for "pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treament of cancer".

Company Profile

0.19.21

Buhr; Chris A. - Redwood City CA
Buhr, Chris A. - Daly City CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazole kinase modulators and methods of use Grant 8,710,038 - Baik , et al. April 29, 2	2014-04-29
Pyrido [2, 3-D] pyrimidin-7-one compounds as inhibitors of P13K-Alpha for the treament of cancer App 20130343988 - Buhr; Chris A. ; et al.	2013-12-26
Pyridopyrimidinone inhibitors of PI3K.alpha. for the treatment of cancer Grant 8,247,408 - Baik , et al. August 21, 2	2012-08-21
Pyridopyrimidinone inhibitors of PI3K.alpha. and mTOR Grant 8,101,622 - Baik , et al. January 24, 2	2012-01-24
Substituted pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors of phospatidylinositol 3-kinase alpha Grant 8,044,062 - Baik , et al. October 25, 2	2011-10-25
Pyridopyrimidinone Inhibitors of PI3Kalpha App 20110237608 - Baik; Tae-Gon ; et al.	2011-09-29
Tropane compounds Grant 8,012,956 - Rice , et al. September 6, 2	2011-09-06
Inhibitors of mTOR and Methods of Making and Using App 20100305093 - Anand; Neel Kumar ; et al.	2010-12-02
Pyrido [2, 3-d] Pyrimidin-7-one Compounds As Inhibitors Of P13k-alpha For The Treatment Of Cancer App 20100209340 - Buhr; Chris A. ; et al.	2010-08-19
Pyrido [2, 3-d] Pyrimidin-7-one Compounds As Inhibitors Of P13k-alpha For The Treatment Of Cancer App 20100150827 - Buhr; Chris A. ; et al.	2010-06-17
Protein kinase modulators and methods of use Grant 7,704,995 - Buhr , et al. April 27, 2	2010-04-27
PYRIDOPYRIMIDINONE INHIBITORS OF PI3K-ALPHA and mTOR App 20100087456 - Baik; Tae-Gon ; et al.	2010-04-08
Pyridopyrimidinone Inhibitors of Pl3Kalpha App 20090270430 - Baik; Tae-Gon ; et al.	2009-10-29
Azepinoindole Derivatives As Pharmaceutical Agents App 20090203577 - Baik; Tae-Gon ; et al.	2009-08-13
Tropane compounds App 20090163471 - Rice; Kenneth D. ; et al.	2009-06-25
Indazole Compounds And Methods Of Use Thereof App 20090099178 - Bhagwat; Shripad S. ; et al.	2009-04-16
Pyridopyrimidinone inhibitors of pi3kalpha App 20090062274 - Baik; Tae-Gon ; et al.	2009-03-05
Pyrazole Kinase Modulators And Methods Of Use App 20070293507 - Baik; Tae-Gon ; et al.	2007-12-20
Methods of using indazole derivatives as JNK inhibitors Grant 7,220,771 - Bhagwat , et al. May 22, 2	2007-05-22
Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith Grant 7,211,594 - Bhagwat , et al. May 1, 2	2007-05-01
Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith Grant 7,208,513 - Bhagwat , et al. April 24, 2	2007-04-24
Protein kinase modulators and methods of use App 20060211709 - Buhr; Chris A. ; et al.	2006-09-21
Indazole compounds and methods of use thereof App 20060004043 - Bhagwat; Shripad S. ; et al.	2006-01-05
2' Modified oligonucleotides App 20050171048 - Buhr, Chris A. ; et al.	2005-08-04
2' Modified oligonucleotides Grant 6,911,540 - Buhr , et al. June 28, 2	2005-06-28
Indazole derivatives as JNK inhibitors and compositions and methods related thereto Grant 6,897,231 - Bhagwat , et al. May 24, 2	2005-05-24
Indazole derivatives as JNK inhibitors and compositions and methods related thereto App 20050107457 - Bhagwat, Shripad S. ; et al.	2005-05-19
Indazole compounds, compositions thereof and methods of treatment therewith App 20050009876 - Bhagwat, Shripad S. ; et al.	2005-01-13
Methods for treating an inflammatory condition or inhibiting JNK App 20040127536 - Bhagwat, Shripad S. ; et al.	2004-07-01
Nucleoside hydrogen phosphonodithioate diesters and activated phosphonodithioate analogues Grant 6,756,496 - Froehler , et al. June 29, 2	2004-06-29
Indazole derivatives as JNK inhibitors and compositions and methods related thereto App 20040077877 - Bhagwat, Shripad S. ; et al.	2004-04-22
2' modified oligonucleotides App 20030036649 - Buhr, Chris A. ; et al.	2003-02-20
2' Modified oligonucleotides Grant 6,476,205 - Buhr , et al. November 5, 2	2002-11-05
Indazole derivatives as JNK inhibitors and compositions and methods related thereto App 20020103229 - Bhagwat, Shripad S. ; et al.	2002-08-01
2' Modified Oligonucleotides Grant 5,792,847 - Buhr , et al. August 11, 1	1998-08-11
Nucleoside hydrogen phosphonodithioate diesters and activated phosphonodithioate analogues Grant 5,565,555 - Froehler , et al. October 15, 1	1996-10-15
Oligonucleotide having enhanced binding affinity Grant 5,486,603 - Buhr January 23, 1	1996-01-23
2'modified nucleoside and nucleotide compounds Grant 5,466,786 - Buhr , et al. November 14, 1	1995-11-14
Hydrogen phosphonodithioate compositions Grant 5,194,599 - Froehler , et al. March 16, 1	1993-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.